Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Bailey

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Plos Pathogens|April 11, 2009
Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kineticsKara G Lassen, Michael A Lobritz, Justin R Bailey, et al.
AIDS (London, England)|May 16, 2021
Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIVJake A Ruddy, Brian J Boyarsky, William A Werbel, et al.
Viral Immunology|October 21, 2021
Decreased Activated CD4<sup>+</sup> T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4<sup>+</sup> T Cell RecoveryNicole E Skinner, Candelaria Vergara, Ramy El-Diwany, et al.
Journal of Virology|May 23, 2008
Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressorJustin R Bailey, Karen O'Connell, Hung-Chih Yang, et al.
Journal of Virology|December 8, 2006
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressorsJoel N Blankson, Justin R Bailey, Seema Thayil, et al.
Plos Pathogens|February 25, 2017
Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1Ramy El-Diwany, Valerie J Cohen, Madeleine C Mankowski, et al.
The Journal of Clinical Investigation|August 14, 2019
Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearanceValerie J Kinchen, Guido Massaccesi, Andrew I Flyak, et al.
The Journal of Infectious Diseases|March 19, 2026
Single-cell hepatitis B sequencing reveals distinct viral infection events consistent with superinfectionMonika Mani, Steven J Clipman, Justin R Bailey, et al.
Plos Pathogens|January 6, 2022
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infectionClinton O Ogega, Nicole E Skinner, Andrew I Flyak, et al.
Journal of Virology|May 10, 2019
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2Michelle D Colbert, Andrew I Flyak, Clinton O Ogega, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Plos Pathogens|April 11, 2009
Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kineticsKara G Lassen, Michael A Lobritz, Justin R Bailey, et al.
AIDS (London, England)|May 16, 2021
Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIVJake A Ruddy, Brian J Boyarsky, William A Werbel, et al.
Viral Immunology|October 21, 2021
Decreased Activated CD4<sup>+</sup> T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4<sup>+</sup> T Cell RecoveryNicole E Skinner, Candelaria Vergara, Ramy El-Diwany, et al.
Journal of Virology|May 23, 2008
Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressorJustin R Bailey, Karen O'Connell, Hung-Chih Yang, et al.
Journal of Virology|December 8, 2006
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressorsJoel N Blankson, Justin R Bailey, Seema Thayil, et al.
Plos Pathogens|February 25, 2017
Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1Ramy El-Diwany, Valerie J Cohen, Madeleine C Mankowski, et al.
The Journal of Clinical Investigation|August 14, 2019
Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearanceValerie J Kinchen, Guido Massaccesi, Andrew I Flyak, et al.
The Journal of Infectious Diseases|March 19, 2026
Single-cell hepatitis B sequencing reveals distinct viral infection events consistent with superinfectionMonika Mani, Steven J Clipman, Justin R Bailey, et al.
Plos Pathogens|January 6, 2022
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infectionClinton O Ogega, Nicole E Skinner, Andrew I Flyak, et al.
Journal of Virology|May 10, 2019
Broadly Neutralizing Antibodies Targeting New Sites of Vulnerability in Hepatitis C Virus E1E2Michelle D Colbert, Andrew I Flyak, Clinton O Ogega, et al.
Pageof 9